Xmichael A. Charles
FDA investigator
Appears on 1 document from 2016. Most often cites written procedures; deviations (21 CFR 211.100(b)).
- 1
- Documents on file
- 8.0
- Observations per 483
- 2016
- First seen
- 2016
- Most recent
What they cite most
From 8 observations- 21 CFR 211.100(b)Written procedures; deviations1
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.42(c)(10)(iv)Design and construction features1
- 21 CFR 211.56(b)Sanitation1
Activity by year
2016: 1
Is Xmichael A. Charles coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2016-07-19 | 483 Kaysersberg Pharmaceuticals SASJul 19, 2016 | — | 8 |
About this profile
What does Xmichael A. Charles inspect?
Xmichael A. Charles appears on 1 document on file.
What do they cite most often?
21 CFR 211.100(b) (written procedures; deviations), followed by 21 CFR 211.110(a) and 21 CFR 211.160(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Xmichael A. Charles is dated Jul 19, 2016.